# Cannabis and Opioid Use Disorder

> **NCT05729932** · PHASE1 · RECRUITING · sponsor: **University of Kentucky** · enrollment: 15 (estimated)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **DRUG:** Inhaled vaporized cannabis
- **DRUG:** Intransal opioid

## Key facts

- **NCT ID:** NCT05729932
- **Lead sponsor:** University of Kentucky
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-10
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2025-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05729932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05729932, "Cannabis and Opioid Use Disorder". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05729932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*